logo
CanyamAI summaries for academic research
language
MobileMobile
  • Phone FeatureWeChat Mini Program
EnglishEnglish
noticeNotice
BlogBlog
delete
arrow
BackJournal Details
Expert Opinion on Therapeutic Targets cover

Expert Opinion on Therapeutic Targets

IF4.4
Papers147
Citations6365
Journal Papers 139
Publication Date
delete
Targeting the LOX-1 scavenger receptor for therapeutics and diagnostics
deleteExpert Opinion on Therapeutic Targets
IF4.4
delete2026-10-04
delete0
deleteOAAI
deleteSreenivasan Ponnambalam; Dhananjay Jade; Michael A. Harrison; Samit Chakrabarty; Sam L. Stephen
deleteShare
deleteSave
Structure-guided targeting of Plasmodium falciparum aminopeptidase P: exploiting S4’ dimer-interface interactions for selective antimalarial drug design
deleteExpert Opinion on Therapeutic Targets
IF4.4
delete2026-10-03
delete0
deleteOAAI
deleteR. Elwyn Isaac; Glenn A. McConkey; Richard Foster; K. Ravi Acharya
deleteShare
deleteSave
Targeting the serotonin 1B receptor for the treatment of depression and anxiety
deleteExpert Opinion on Therapeutic Targets
IF4.4
delete2026-09-28
delete0
PREAI
deleteSixtine Fleury; Katherine M. Nautiyal
deleteShare
deleteSave
Senolytics for cancer treatment: complexities and opportunities
deleteExpert Opinion on Therapeutic Targets
IF4.4
delete2026-09-27
delete0
PREAI
deleteSofian Al Shboul; David A. Gewirtz; Tareq Saleh
deleteShare
deleteSave
Sirtuin signaling as therapeutic targets of immunosenescence
deleteExpert Opinion on Therapeutic Targets
IF4.4
delete2026-09-25
delete0
PREAI
deleteAnna Calabrò; Giulia Accardi; Anna Aiello; Calogero Caruso; Damiano Galimberti; Chiara Puleo; Rosa Zarcone; Giuseppina Candore
deleteShare
deleteSave
Molecular insights into GLP-1 receptor agonists and emerging metabolic-inflammatory targets in hidradenitis suppurativa
deleteExpert Opinion on Therapeutic Targets
IF4.4
delete2026-09-24
delete0
PREAI
deleteEmma Brogaard; Valdemar Wendelboe Nielsen; Nadja Højgaard Pedersen; Simon Francis Thomsen
deleteShare
deleteSave
Enhancing the glymphatic system as a potential pathway to limit Parkinson disease progression
deleteExpert Opinion on Therapeutic Targets
IF4.4
delete2026-09-24
delete0
deleteOAAI
deleteZhao Yan; Jason Howitt
deleteShare
deleteSave
Targeting the Orai1 CRAC channel: translating molecular insights into therapeutic progress
deleteExpert Opinion on Therapeutic Targets
IF4.4
delete2026-09-23
delete0
PREAI
deleteIsaac Jardín; Alvaro Macias-Díaz; Vanesa Jimenez-Velarde; Manuel Fuentes-Mateos; Tarik Smani; Juan A. Rosado
deleteShare
deleteSave
In the wisdom of Odin: modular architecture, receptor trafficking and therapeutic implications
deleteExpert Opinion on Therapeutic Targets
IF4.4
delete2026-09-22
delete0
PREAI
deleteValeria Pennacchietti; Francesca Malagrinò; Stefano Gianni
deleteShare
deleteSave
Molecular targets in proliferative vitreoretinopathy: rethinking prevention, treatment and drug delivery after rhegmatogenous retinal detachment
deleteExpert Opinion on Therapeutic Targets
IF4.4
delete2026-09-08
delete0
PREAI
deleteEnrico Bernardi; William Mitchell; Carla Troyas; Rodrigo Anguita
deleteShare
deleteSave
Exploiting ER proteostasis in malaria: protein disulphide isomerases as selective antimalarial targets
deleteExpert Opinion on Therapeutic Targets
IF4.4
delete2026-09-06
delete0
deleteOAAI
deleteAdeshina I. Odugbemi; Wendy Mthembu; Tawanda Zininga
deleteShare
deleteSave
Hepatic T-cell dysfunction in chronic liver disease and hepatocellular carcinoma: a spatial systems-immunology framework for precision immunotherapy
deleteExpert Opinion on Therapeutic Targets
IF4.4
delete2026-08-26
delete0
PREAI
deleteWanvisa Udomsinprasert
deleteShare
deleteSave
Interleukin-6 as a therapeutic target in diabetic macular edema: current evidence and future perspectives
deleteExpert Opinion on Therapeutic Targets
IF4.4
delete2026-08-18
delete0
PREAI
deleteHidetaka Noma; Tatsuya Mimura
deleteShare
deleteSave
ACK family tyrosine kinases as potential therapeutic targets for cancer
deleteExpert Opinion on Therapeutic Targets
IF4.4
delete2026-07-28
delete0
PREAI
deleteRadhika Mittal; Priya Priya; Jyotirmoy Banerjee; Aparna Banerjee Dixit
deleteShare
deleteSave
Hepatocyte nuclear factor 4α – prospects for therapeutic targeting
deleteExpert Opinion on Therapeutic Targets
IF4.4
delete2026-07-01
delete0
deleteOAAI
deleteYusuke Inoue
deleteShare
deleteSave
Molecular insights for targeting the Nrf1 pathway in hepatocellular carcinoma
deleteExpert Opinion on Therapeutic Targets
IF4.4
delete2026-06-29
delete0
PREAI
deleteXi Chen; Zhengwen Zhang; Siqian Cui; Yiguo Zhang
deleteShare
deleteSave
The protective role of SIRT1 in cardiovascular disease: from molecular mechanisms to potential therapeutic strategies
deleteExpert Opinion on Therapeutic Targets
IF4.4
delete2026-06-21
delete0
PREAI
deleteHaixin Ma; Shuya Wang; Zijian Dang; Wentao Xie; Ning Li; Jiayan Li; Yang Yang; Zhenxiao Jin
deleteShare
deleteSave
Therapeutic activation of the endocannabinoid system for opioid use disorder, chronic pain, and cancer-related pain: a review of current evidence
deleteExpert Opinion on Therapeutic Targets
IF4.4
delete2026-06-19
delete0
PREAI
deleteOluseun Dairo; Jocelyn A. Mitchell-Williams; Ping Zhang
deleteShare
deleteSave
The AT2 receptor as a potential target for autosomal dominant polycystic kidney disease therapy?
deleteExpert Opinion on Therapeutic Targets
IF4.4
delete2026-06-15
delete0
deleteOAAI
deleteYan Wang; Sharon Ricardo; Robert Widdop
deleteShare
deleteSave
Targeting inflammatory persistence in axial spondyloarthritis: from cytokine blockade to pathway convergence
deleteExpert Opinion on Therapeutic Targets
IF4.4
delete2026-06-14
delete0
deleteOAAI
deleteDimitrios Deligeorgakis; Nikolaos Kougkas
deleteShare
deleteSave